1. Home
  2. MOB vs ABVC Comparison

MOB vs ABVC Comparison

Compare MOB & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobilicom Limited

MOB

Mobilicom Limited

N/A

Current Price

$1.43

Market Cap

30.9M

Sector

Real Estate

ML Signal

N/A

Logo ABVC BioPharma Inc.

ABVC

ABVC BioPharma Inc.

N/A

Current Price

$0.89

Market Cap

26.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MOB
ABVC
Founded
2008
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.9M
26.7M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
MOB
ABVC
Price
$1.43
$0.89
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $11.00
N/A
AVG Volume (30 Days)
★ 174.1K
29.4K
Earning Date
08-13-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 7.14
EPS
★ N/A
N/A
Revenue
N/A
★ $509,589.00
Revenue This Year
$76.34
N/A
Revenue Next Year
$109.65
$171.50
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.38
$0.71
52 Week High
$9.78
$2.87

Technical Indicators

Market Signals
Indicator
MOB
ABVC
Relative Strength Index (RSI) 22.71 38.71
Support Level N/A $0.71
Resistance Level $6.89 $1.12
Average True Range (ATR) 0.32 0.07
MACD -0.07 -0.01
Stochastic Oscillator 5.56 11.21

Price Performance

Historical Comparison
MOB
ABVC

About MOB Mobilicom Limited

Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Share on Social Networks: